Medication self-management in consumers with diabetes and kidney disease from culturally and linguistically diverse backgrounds

Phase 2

Recruiting

• Conditions: diabetes and kidney disease; Metabolic and Endocrine - Diabetes; Renal and Urogenital - Kidney disease; Cardiovascular - Hypertension

• Registration Number: ACTRN12608000313336
• Lead Sponsor: The University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-07-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

Victorians whose preference is to speak either Greek, Italian or Vietnamese at home Diabetes, kidney disease and cardiovascular disease Mentally competent

Exclusion Criteria

Pregnancy
Imminent end stage kidney disease Aggressive form of cancer
Mental illness not stabilised with medication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medication self-efficacy will be measured by the <br>Medication Adherence Self-efficacy scale.[Immediately post-intervention at 12 weeks and 3 months post-intervention]

Secondary Outcome Measures

Name	Time	Method
Improved medication adherence which will be measured by the Morisky Medication Adherence scale[Immediately post-intervention at 12 weeks and 3 months post-intervention]